Morgan Stanley’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Morgan Stanley’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,899,497	Closed	-$80M	–	7745
2023 Q2	$80M	Buy	1,899,497 +328,982	+21%	+$13.3M	0.01%	1227
2023 Q1	$55.9M	Sell	1,570,515 -140,588	-8%	-$5.1M	0.01%	1449
2022 Q4	$62.8M	Buy	1,711,103 +1,016,660	+146%	+$40.2M	0.01%	1324
2022 Q3	$32.7M	Buy	694,443 +118,680	+21%	+$7.67M	﹤0.01%	1686
2022 Q2	$41.3M	Buy	575,763 +336,610	+141%	+$24.6M	0.01%	1538
2022 Q1	$19.4M	Sell	239,153 -743,705	-76%	-$62.9M	﹤0.01%	2152
2021 Q4	$101M	Sell	982,858 -275,213	-22%	-$26.4M	0.01%	888
2021 Q3	$110M	Buy	1,258,071 +24,939	+2%	+$2.26M	0.01%	799
2021 Q2	$110M	Buy	1,233,132 +461,907	+60%	+$39M	0.01%	798
2021 Q1	$58.5M	Buy	771,225 +217,861	+39%	+$16.4M	0.01%	1059
2020 Q4	$37.7M	Buy	553,364 +66,452	+14%	+$4.14M	0.01%	1311
2020 Q3	$25.9M	Buy	486,912 +463,439	+1,974%	+$27.6M	0.01%	1296
2020 Q2	$1.37M	Sell	23,473 -38,424	-62%	-$2.07M	﹤0.01%	3927
2020 Q1	$2.44M	Sell	61,897 -64,301	-51%	-$3.76M	﹤0.01%	3183
2019 Q4	$7.5M	Buy	126,198 +94,709	+301%	+$5.09M	﹤0.01%	2743
2019 Q3	$1.68M	Buy	31,489 +16,486	+110%	+$846K	﹤0.01%	3936
2019 Q2	$766K	Sell	15,003 -11,734	-44%	-$546K	﹤0.01%	4376
2019 Q1	$1.38M	Sell	26,737 -82,134	-75%	-$3.98M	﹤0.01%	3886
2018 Q4	$4.28M	Sell	108,871 -52,688	-33%	-$2.45M	﹤0.01%	3071
2018 Q3	$8.33M	Sell	161,559 -22,043	-12%	-$1.08M	﹤0.01%	2604
2018 Q2	$8.61M	Sell	183,602 -51,241	-22%	-$2.12M	﹤0.01%	2534
2018 Q1	$8.34M	Buy	234,843 +2,706	+1%	+$106K	﹤0.01%	2514
2017 Q4	$10.1M	Sell	232,137 -1,459	-0.6%	-$68.2K	﹤0.01%	2379
2017 Q3	$12.2M	Sell	233,596 -207,276	-47%	-$11.6M	﹤0.01%	2077
2017 Q2	$25.8M	Buy	440,872 +292,698	+198%	+$15.2M	0.01%	1318
2017 Q1	$6.79M	Sell	148,174 -27,800	-16%	-$1.38M	﹤0.01%	2554
2016 Q4	$9.26M	Buy	175,974 +80,164	+84%	+$3.88M	﹤0.01%	2331
2016 Q3	$4.27M	Sell	95,810 -130,444	-58%	-$5.66M	﹤0.01%	2815
2016 Q2	$8.63M	Buy	226,254 +13,908	+7%	+$611K	﹤0.01%	2120
2016 Q1	$8.75M	Sell	212,346 -76,228	-26%	-$3.14M	﹤0.01%	1978
2015 Q4	$14M	Sell	288,574 -50,900	-15%	-$2.26M	0.01%	1700
2015 Q3	$13.6M	Buy	339,474 +214,982	+173%	+$9.39M	0.01%	1693
2015 Q2	$5M	Buy	124,492 +30,443	+32%	+$1.05M	﹤0.01%	2795
2015 Q1	$3.08M	Buy	94,049 +28,743	+44%	+$794K	﹤0.01%	3177
2014 Q4	$1.68M	Buy	+65,306	New	+$1.55M	﹤0.01%	3711

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's SYNH Position: Q3 2023 in Review

Morgan Stanley sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,899,497 shares — an estimated $80M sold.

Morgan Stanley first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $110M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Morgan Stanley reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Morgan Stanley sold 1,899,497 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $80M.
Morgan Stanley first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Morgan Stanley's Syneos Health, Inc. Class A Common Stock position peaked at $110M in Q2 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.